Since EGFR mutation is an important oncogenic driver mutations in NSCLC, we further investigated whether or not EGFR mutation status associates with the prognostic performance of OGT, OGA, or O-GlcNAc [17]. Here, OGT is linked to non-small cell lung carcinoma.